|
Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea |
|
|
|
Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2013 Authors' conclusions Obstructive sleep apnea (OSA) is a breathing disorder that is defined by either a decrease or complete cessation of airflow during sleep. Airflow obstruction arises when the muscles in the back of the throat fail to keep the airway open. OSA is characterized by repetitive pauses in breathing during sleep, despite the effort to breathe, and is usually associated with a reduction in blood oxygen saturation. These pauses in breathing, called apneas, typically last 20 to 40 seconds. Hypopnea involves episodes of overly shallow breathing or an abnormally low respiratory rate. Hypopnea differs from apnea in that there remains some flow of air. Untreated OSA is associated with symptoms of sleep deprivation and excessive sleepiness, cognitive dysfunction, diminished quality of life and productivity, sexual dysfunction, mood changes, increased accident risk, and cardiovascular disease and stroke. OSA has an estimated prevalence of 9% in women and 24% in men. Treatment of OSA includes behavioral therapy (e.g., weight loss), drug therapy, continuous positive airway pressure (CPAP), oral appliances, palatal implants, and surgery. CPAP is the firstline treatment for patients with moderate to severe OSA, with a treatment success rate of nearly
100% when used properly. CPAP provides a constant flow of air delivered through a face mask worn while sleeping to keep the upper airway open; however, patients frequently complain of the intrusive nature of the device, resulting in lack of acceptance or partial adherence. Thus, there is a need for additional therapeutic options that are less intrusive and simpler to use. Indexing Status Subject indexing assigned by CRD MeSH Humans; Sleep Apnea, Obstructive Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32013000840 Date abstract record published 13/11/2013 |
|
|
|